Greater Cannabis Company (GCAN) Non Operating Income (2016 - 2025)
Greater Cannabis Company (GCAN) recorded quarterly Non Operating Income of $391563.0 in Q4 2025, up 29722.01% quarter-over-quarter from $1313.0 in Q3 2025, and up 6941.92% on a YoY basis from $5560.5 in Q4 2024.
Greater Cannabis Company (GCAN) Non Operating Income (2016 - 2025) Analysis & Trends
Greater Cannabis Company's Non Operating Income history runs 10 years deep, the most recent figure standing at $391563.0 for Q4 2025.
- In Q4 2025, Non Operating Income rose 6941.92% year-over-year to $391563.0; the TTM figure through Dec 2025 stood at -$9701.0 (up 57.39% YoY), while the FY2025 annual figure was -$148607.0, down 552.79% from the prior year.
- Non Operating Income was $391563.0 for Q4 2025 at Greater Cannabis Company, up from $1313.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $391563.0 in Q4 2025 to a low of -$342602.0 in Q2 2025.
- Historically, Non Operating Income has averaged -$24390.8 across 5 years, with a median of -$5691.0 in 2024.
- Biggest YoY gain for Non Operating Income was 6941.92% in 2025; the steepest drop was 5953.04% in 2025.
- A 5-year view of Non Operating Income shows it stood at -$76229.0 in 2021, then jumped by 93.27% to -$5134.0 in 2022, then surged by 44.8% to -$2834.0 in 2023, then plunged by 101.94% to -$5723.0 in 2024, then soared by 6941.92% to $391563.0 in 2025.
- The last three Non Operating Income figures came in at $391563.0 (Q4 2025), $1313.0 (Q3 2025), and -$342602.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Greater Cannabis Company | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 391,563.00 |
| Sep 30, 2025 | 1,313.00 |
| Jun 30, 2025 | -342,602.00 |
| Mar 31, 2025 | -59,975.00 |
| Dec 31, 2024 | -5,723.00 |
| Sep 30, 2024 | -5,722.00 |
| Jun 30, 2024 | -5,660.00 |
| Mar 31, 2024 | -5,660.00 |
| Dec 31, 2023 | -2,834.00 |
| Sep 30, 2023 | -2,965.00 |
| Jun 30, 2023 | -3,639.00 |
| Mar 31, 2023 | -3,600.00 |
| Dec 31, 2022 | -5,134.00 |
| Sep 30, 2022 | -53,472.00 |
| Jun 30, 2022 | -19,371.00 |
| Mar 31, 2022 | -105,256.00 |
| Dec 31, 2021 | -76,229.00 |
| Sep 30, 2021 | -177,940.00 |
| Jun 30, 2021 | 23,510.00 |
| Mar 31, 2021 | -28,421.00 |